CSI Market
Sign In | Register

Adaptimmune Therapeutics Plc (ADAP) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access ADAP Annual Balance Sheets →
The table below presents a historical view of Adaptimmune Therapeutics Plc's balance sheet, supporting analysis of financial position trends.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2025)
(Mar 31 2025) (Dec 31 2024) (Sep 30 2024) (Jun 30 2024)
Assets
Cash & cash equivalent26.06
Available-for-sale Securities, Debt Securities, Current MA0.00
Cash & Short-term Investments26.00
Accounts receivable9.31
Notes Receivable, Current1.31
Inventories0.49
Other Current Assets0.00
Prepaid Expense And Other Assets Current31.33
Total Current Assets78.12
Equipment/Property/Plant Net75.03
Intangible Assets6.14
Long-term investments1.72
Tax Assets, Noncurrent0.00
Other Assets, Noncurrent20.00
Total Assets130.63
Liabilities
Accounts Payable, Current AC9.42
Accrued Liabilities, Current AC24.53
Other Liabilities, Current17.57
Total Current Liabilities51.51
Long-term debt25.68
Total Long-term Debt25.68
Restructuring Reserve LI2.36
Deferred Revenue, Noncurrent DE0.00
Accrued Income Taxes, Noncurrent0.00
Discontinued Operation, Noncurrent5.91
Other liabilities, Noncurrent122.05
Operating Lease Liability Current4.51
Contract With Customer Liability Current10.70
Operating Lease Liability Noncurrent18.49
Total Liabilities201.59
Stockholders' Equity
Common Stock Value2.16
Additional Paid In Capital Common Stock1,109.41
Retained Earnings / Accumulated Deficit-1,171.91
Accumulated Other Comprehensive Income-10.61
Other Equity-10.61
Common Stockholder's Equity-70.96
Total Stockholder's Equity-70.96
Liabilities & Stockholder's Equity130.63
4 historic quarters locked

Sign in to unlock the full Adaptimmune Therapeutics Plc balance sheet history.

Sign In Create Free Account

About Adaptimmune Therapeutics Plc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001558370-25-011307

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.